Showing results (1391-1400 of 1,873) with videos related to
Sort By:
Pageof 188
Plos One|March 21, 2022
Cytochrome P450 168A1 from Pseudomonas aeruginosa is involved in the hydroxylation of biologically relevant fatty acidsClaire L Price, Andrew G S Warrilow, Nicola J Rolley, et al.The FEBS Journal|December 14, 2011
Investigating conservation of the albaflavenone biosynthetic pathway and CYP170 bifunctionality in streptomycetesSuzy C Moody, Bin Zhao, Li Lei, et al.Schizophrenia Bulletin|November 5, 2014
Rasagiline in the Treatment of the Persistent Negative Symptoms of SchizophreniaRobert W Buchanan, Elaine Weiner, Deanna L Kelly, et al.Pharmaceuticals (Basel, Switzerland)|August 2, 2017
The Binding Effect of Proteins on Medications and Its Impact on Electrochemical Sensing: Antipsychotic Clozapine as a Case StudyGeorge E Banis, Thomas Winkler, Patricia Barton, et al.Journal of Neuropsychiatry (Foster City, Calif.)|February 26, 2019
Peripheral Cortisol and Inflammatory Response to a Psychosocial Stressor in People with SchizophreniaMatthew Glassman, Heidi J Wehring, Ana Pocivavsek, et al.Journal of Neurosurgery|September 6, 2024
Novel application of latent class analysis to outcome assessment in traumatic brain injury with multiple injury subtypes or poly-TBISamuel Doty, Jordan C Petitt, Ahmed Kashkoush, et al.Transplant Immunology|December 3, 2014
Impaired CD8(+) T cell immunity after allogeneic bone marrow transplantation leads to persistent and severe respiratory viral infectionKymberly M Gowdy, Tereza Martinu, Julia L Nugent, et al.Schizophrenia Research|December 4, 2014
Risk-taking in schizophrenia and controls with and without cannabis dependenceBernard A Fischer, Robert P McMahon, Deanna L Kelly, et al.Blood Advances|January 28, 2020
BCL-W is dispensable for the sustained survival of select Burkitt lymphoma and diffuse large B-cell lymphoma cell linesSarah T Diepstraten, Catherine Chang, Lin Tai, et al.Journal of Clinical Psychopharmacology|June 8, 2017
A Randomized Clinical Trial of Oxytocin or Galantamine for the Treatment of Negative Symptoms and Cognitive Impairments in People With SchizophreniaRobert W Buchanan, Deanna L Kelly, Elaine Weiner, et al.Pageof 188